LivaNova is the Australian and NZ distributor for Medistim ASA, a niche market leader within ultrasound technology with headquarters in Norway, that develops and commercializes medical equipment for use within cardiac, vascular and transplant surgery.

Cardiac and vascular diseases continue to be the most common cause of death in the western world. Globally, more than 700.000 patients undergo coronary artery bypass surgery annually while about 600.000 patients have vascular surgery procedures performed. Medistim’s mission over the past three decades has been to serve patients, surgeons and health care providers with innovative and cost effective medical devices that measure blood flow and visualize atherosclerosis, and thereby help improve the quality and outcome of cardiac and vascular surgery.